Does ARIPIPRAZOLE Cause Mobility decreased? 95 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Mobility decreased have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.1% of all adverse event reports for ARIPIPRAZOLE.
95
Reports of Mobility decreased with ARIPIPRAZOLE
0.1%
of all ARIPIPRAZOLE reports
1
Deaths
20
Hospitalizations
How Dangerous Is Mobility decreased From ARIPIPRAZOLE?
Of the 95 reports, 1 (1.1%) resulted in death, 20 (21.1%) required hospitalization, and 2 (2.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
Yes, Mobility decreased is listed as a known adverse reaction in the official FDA drug label for ARIPIPRAZOLE.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ARIPIPRAZOLE Alternatives Have Lower Mobility decreased Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE